Key factors may predict which women benefit from preterm labor delay treatment

NCT ID NCT07696858

Not yet recruiting Knowledge-focused Sponsor: Sohag University Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study looks at 100 pregnant women with a single baby who are experiencing preterm labor between 24 and 34 weeks. Researchers aim to find which factors help predict whether a short course of tocolysis (medication to delay labor) can postpone delivery by at least 48 hours. The goal is to better understand who is most likely to benefit from this treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify which women are most likely to benefit from tocolysis, potentially improving preterm labor management.
What could go wrong: This is an observational study, not a treatment trial. It identifies associations, not causes, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRETERM LABOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obstetric Labor, Premature

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRETERM LABOR

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.